Stock Price
1.30
Daily Change
0.05 4.00%
Monthly
18.18%
Yearly
8.33%
Q2 Forecast
1.22

Actinium Pharmaceuticals reported $90K in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
AbbVie USD 16.62B 840M Dec/2025
Actinium Pharmaceuticals USD 90K 9K Sep/2025
Amgen USD 9.9B 340M Dec/2025
Bioline Rx USD 427K 123K Sep/2025
Capricor Therapeutics USD 11.13M 8.87M Dec/2024
Pfizer USD 17.58B 880M Dec/2025